Further evidence that the one-time much stigmatised marijuana is ‘going places’ in the global medicine and cosmetics industries emerged recently with the reported signing of an Agreement that allows for the Australian-headquartered medicinal ganja company, CANNIM, to legally export the ganja flower into Germany.
Regarded as one of the world’s most significant medicinal ganja markets, Germany’s agreement with CANNIM is a key step towards realising the company’s goal of becoming a global leader in the medicinal and wellness ganja sectors, the company’s Chief Commercial Officer Stuart Marsh says. Marsh reportedly sees the move as representing a “huge opportunity” for CANNIM that “enhances its ability to cultivate high-quality, medical grade Jamaican ganja.”
